Implantable Drug Delivery Devices Market Worth $31.6 Billion By 2025: Grand View Research, Inc.

SAN FRANCISCO, July 9, 2018 /PRNewswire/ --

The global implantable drug delivery devices market [https://www.grandviewresearch.com/industry-analysis/implantable-drug-delivery-devices-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RD1&utm_content=Content ]  size is expected to reach USD 31.6 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.5% CAGR during the forecast period. Growing incidence of chronic diseases, coupled with rising demand for minimally invasive treatment options, is driving the market for implantable drug delivery devices.

(Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg )

Recent advancements in medication administration technologies are expected to fuel market growth over the forecast period. Increase in adoption of micro-scale implantable devices is one of the key factors fueling growth. These products find application in monitoring improvement in body functions, imaging, and medication administration. They facilitate localized treatment with controlled drug administration and enable targeted delivery of therapeutics to tissues.

These devices help overcome limitations of intravenous, oral, and topical administration routes, thus broadening the growth prospects of the market. In addition, advent of biodegradable implants enables targeted delivery of chemotherapeutics to tumor cells without damaging normal cells. Drug releasing implants are also helpful in treatment of inoperable tumors such as that of liver, brain, and lungs, due to their location and size. These devices help in reducing tumor size, which enables surgical removal of tumors. The aforementioned benefits of these devices are expected to impel their adoption over the forecast period.

Manufacturers are focused on developing novel drug delivery devices to gain maximum market share, which has resulted in launch of various technologically advanced products in the market. For instance, in February 2017, Delpor, Inc., a biotechnology company in U.S., announced the launch of an implantable device for long-term delivery of therapeutics.

Browse full research report with TOC on "Implantable Drug Delivery Devices Market Analysis Report By Type (Biodegradable, Non-biodegradable), By Product, By Technology (Diffusion, Osmotic, Magnetic), By Application, And Segment Forecasts, 2018 - 2025" at: https://www.grandviewresearch.com/industry-analysis/implantable-drug-delivery-devices-mark et [https://www.grandviewresearch.com/industry-analysis/implantable-drug-delivery-devices-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RD2&utm_content=Content ]

Further Key Findings From the Report Suggest: 

        
        - By product, drug-eluting stents held a dominant share in the market in 2016, owing
          to their growing adoption in hormone regulation, contraception, pain management, and
          cancer therapy. Bio-absorbable stents, on the other hand, are anticipated to grow at a
          lucrative rate owing to increase in incidence of peripheral and coronary artery
          diseases
        - On the basis of type, the non-biodegradable segment held the largest share in 2016, as
          a consequence of easy availability of these products and their established efficacy
        - Diffusion held a dominant share in the market on the basis of technology, owing to
          significant increase in adoption as it offers better patient outcomes and
          acceptability
        - By application, cardiovascular accounted for a substantial share in 2016 due to
          increasing adoption of drug-eluting and bio-absorbable stents for management of
          cardiovascular diseases. Autoimmune diseases, on the other hand, are expected to
          exhibit the fastest CAGR owing to rising prevalence of multiple sclerosis and
          rheumatoid arthritis
        - While North America held a substantial share in 2016 owing to rising prevalence of
          chronic diseases, unhealthy lifestyles, and high stress levels among the population,
          Asia Pacific is anticipated to achieve significant CAGR through 2025. This is owing to
          improving healthcare systems, rising healthcare expenditure, and growing awareness.

Browse related reports by Grand View Research: 

        
        - Wound Closure Devices Market
          [https://www.grandviewresearch.com/industry-analysis/wound-closure-devices-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RL1&utm_content=Content ]
          - Increasing demand for reduction in surgical 
          expenditure has given rise to the products capable of enhancing therapeutic outcome 
          by reducing hospital stay are the major drivers for the growth of wound closure 
          devices market

        
        - Artificial Ventilation and Anesthesia Masks Market
          [https://www.grandviewresearch.com/industry-analysis/artificial-ventilation-anesthesia-masks-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RL2&utm_content=Content ]
          - The Global artificial 
          ventilation and anesthesia masks market size was valued at USD 1,715.3 million in
          2014.

        
        - Retinal Implant Market
          [https://www.grandviewresearch.com/industry-analysis/retinal-implant-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RL3&utm_content=Content ]
          - The global Retinal Implant Market size was valued at 
          USD 14.01 million in 2015.

        
        - Artificial Vital Organs and Medical Bionics Market
          [https://www.grandviewresearch.com/industry-analysis/artificial-vital-organs-and-medical-bionics-market?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_RL4&utm_content=Content ]
          - The Global artificial 
          vital organs and medical bionics market size was estimated at USD 22.67 billion in
          2014.

Grand View Research has segmented the global implantable drug delivery devices market on the basis of product, type, technology, application, and region: 

        
        - Implantable Drug Delivery Devices Product Outlook (Revenue, USD Million, 2014 -
          2025) 
             - Contraceptive Implants
             - Spinal Implants
             - Brachytherapy Seeds
             - Drug-eluting Stents
             - Bioabsorbable Stents
             - Intraocular Stents
             - Infusion Pumps
             - Others
        - Implantable Drug Delivery Devices Type Outlook (Revenue, USD Million, 2014 - 2025)
           
             - Biodegradable
             - Non-biodegradable
        - Implantable Drug Delivery Devices Technology Outlook (Revenue, USD Million, 2014 -
          2025) 
             - Diffusion
             - Osmotic
             - Magnetic
             - Others
        - Implantable Drug Delivery Devices Application Outlook (Revenue, USD Million, 2014
        - 2025) 
             - Contraception
             - Ophthalmology
             - Cardiovascular
             - Diabetes
             - Oncology
             - Autoimmune Diseases
             - Others
        - Implantable Drug Delivery Devices Regional Outlook (Revenue, USD Million, 2014 -
          2025) 
             - North America
                - U.S.
                - Canada
             - Europe
                - U.K.
                - Germany
             - Asia Pacific
                - Japan
                - China
                - India
             - Latin America
                - Brazil
                - Mexico
             - Middle East & Africa
                - South Africa

Explore the BI enabled intuitive market research database, The Grand Library [https://www.grandviewresearch.com/grand-library?utm_source=pressrelease&utm_medium=referral&utm_campaign=PRN_July09_Implantable_Drug_Delivery_Devices_BI&utm_content=Content ] , by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

        

        Contact: 
        Sherry James 
        Corporate Sales Specialist, USA 
        Grand View Research, Inc. 
        Phone: +1-415-349-0058 
        Toll Free: 1-888-202-9519 
        Email: sales@grandviewresearch.com 

 

Web: https://www.grandviewresearch.com

    Photo: 
    https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg

SOURCE Grand View Research, Inc.